(Q34018753)

English

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Barbara Jarząb

10

object named as

Barbara Jarzab

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Kornelia Hasse-Lazar

3

object named as

Kornelia Hasse-Lazar

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daria Handkiewicz-Junak

1

object named as

Daria Handkiewicz-Junak

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

object named as

Zbigniew Puch

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sylwia Szpak-Ulczok

4

object named as

Sylwia Szpak-Ulczok

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Aleksandra Kukulska

6

object named as

Aleksandra Kukulska

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

object named as

Jozef Roskosz

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

object named as

Tomasz Olczyk

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ewa Paliczka-Cieslik

9

object named as

Ewa Paliczka-Cieslik

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Andrzej Piela

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Thyroid Research

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoic acid redifferentiation therapy for thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Innovative strategies for the treatment of thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Regulation of CD97 protein in thyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

5 July 2018

Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

29 October 2018

Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

29 October 2018

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

29 October 2018

Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

29 October 2018

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739165

29 October 2018

Redifferentiation therapy-induced radioiodine uptake in thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects from the treatment of thyroid carcinoma with radioiodine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotretinoin in metastatic thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19646277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-6614-2-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34018753&oldid=2196121958"